Position in MRK
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$9,048,841
+$472,527 QoQ
Shares Held
70,419
-1.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#782
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Simmons Bank holds $67,934,657 across 11 Drug Manufacturers - General names. MRK ranks #4 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
51,844 | $13,046,023 | |
| 2 | LLY |
ELI LILLY & Co
|
10,864 | $13,030,606 | |
| 3 | AMGN |
Amgen Inc
|
26,161 | $9,473,419 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
70,419 | $9,048,841 | |
| 5 | JNJ |
Johnson & Johnson
|
35,136 | $8,923,488 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
37,464 | $4,733,201 | |
| 7 | PFE |
Pfizer Inc
|
125,117 | $3,012,817 | |
| 8 | GSK |
GSK plc
|
57,449 | $3,011,475 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,048,841 | 70,419 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $8,576,314 | 71,297 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $7,502,930 | 71,280 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $5,924,531 | 70,589 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $5,898,764 | 74,517 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $6,678,591 | 74,405 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $8,170,588 | 82,133 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $9,642,491 | 84,911 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $10,738,039 | 86,737 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $11,719,269 | 88,816 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $9,787,378 | 89,776 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $9,348,887 | 90,810 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $10,496,796 | 90,968 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $9,853,095 | 92,613 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $10,001,698 | 90,146 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $7,768,970 | 90,211 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $8,322,724 | 91,288 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $9,311,114 | 113,481 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $8,846,937 | 115,435 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $8,814,381 | 117,353 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $9,912,484 | 127,459 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $10,406,846 | 134,996 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $11,689,130 | 142,899 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $12,483,065 | 150,489 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $11,870,081 | 153,499 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $11,571,614 | 150,398 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||